Metastatic Breast Cancer: What Is the Way Forward?

Hi Renukaprasad A R, Does abemaciclib serve as an effective treatment regimen in HR+/HER2- metastatic breast cancer (MBC) patients? To address this question, Eli Lilly brings you a panel discussion and a live Q&A session, where Dr. Anwar Al Nouri (Kuwait), Dr. Shyam Aggarwal, Dr. J. B. Sharma, Dr. Sushant Mittal, Dr. Samit Purohit, and Dr. Priya Tiwari will share their clinical experiences about the benefits of abemaciclib in MBC patients and how it helps patients with liver metastasis and poor prognosis. The experts will also discuss how to tailor abemaciclib treatment based on prognostic factors. Ramiven� Different by Design: New Delhi Chapter Join us TODAY at 07:30 PM IST. Looking forward to your active participation in this informative discussion. Session Details: Abemaciclib as a first-line therapy - Dr. Anwar Al Nouri Clinical case presentation I - Dr. Anwar Al Nouri Clinical case presentation II - Dr. J. B. Sharma Clinical case presentation III - Dr. Sushant Mittel Clinical case presentation IV - Dr. Samit Purohit Q&A with the experts: Tailoring treatment in HR+/HER2- MBC based on prognostic factors Click to Join Happy Docplexing India's Largest Online Community Of Doctors Pune - 411045, India info@docplexus.co.in   |  +91 98500 36954 Change email preference | Unsubscribe